Dr. Joseph P. Balint. Ph.D.
Dr. Balint is a trained immunologist with 25 years of experience in academic and corporate environments. He has taken products from the bench to the bedside, gaining FDA and ISO licensing. Dr. Balint is currently directing Etubics’ laboratory operations where works at the laboratory bench, writes government research grant applications, prepares publications and is in charge of Company intellectual property. He performs animal and human immune assays, serology testing, and cell-line operations. From 1982 to 1989 he was Director of Extracorporeal Products, IMRÉ CORPORATION; from 1989 to 1993 he was head of Product Development and from 1986 to 1996, he was head of the company’s clinical diagnostic laboratory.
Dr. Balint holds a Ph.D. from Rutgers University (Microbiology) and has ASCP certification in Microbiology. He has 10 patents to his name and has published over 45 scientific papers.
Dr. Adrian Rice, Ph.D.
Vice President, Research
Dr. Rice is an immunologist with an extensive background and practices at Etubics Corporation cellular immunology, antigen processing/presentation, T cell and dendritic cell biology, molecular biology, biochemistry and structural biology. He has been a member of Etubics Corporation research and development team since 2013, where he focuses on developing the Company’s adenoviral Etubics Platform immunotherapy platforms targeting cancers and infectious diseases.
Dr. Rice received his Ph.D. from the California Institute of Technology in Biochemistry and Molecular Biophysics where he was the recipient of the National Science Foundation Graduate Research Fellowship Award. He held a post-doctoral training position in the laboratory of Prof. Michael J. Bevan at the University of Washington Department of Immunology. In addition, he has co-authored 11 scientific publications and presented at and participated in multiple immunotherapy conferences.
Dr. Jessica Sneeden, Ph.D.
Dr. Sneeden performs construction and isolation of Etubics Corporation product candidates. She has over 17 years of combined graduate and professional experience in the design and characterization of proteins with novel properties via protein engineering and development of novel library selection methods. She has an extensive background in protein expression and purification, protein/nucleic acid interactions and enzyme characterization, DNA recombination and repair pathways, with emphasis on DNA polymerases and their interaction with repair factors and DNA. She has previously held positions at the University of Washington, Stratos Genomics, Inc., and the University of California Davis. In addition, she completed her postdoctoral fellowship at the University of Southern California.
Dr. Sneeden holds a Ph.D. in biochemistry from the University of Washington and an undergraduate degree in biochemistry from North Carolina State University. Dr. Sneeden has authored scientific 13 publications and presented her data at multiple conferences.